Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chételat

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Revue Neurologique|May 3, 2022
How to use neuroimaging biomarkers in the diagnosis framework of neurodegenerative diseases?G Chételat
Revue Neurologique|September 11, 2013
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriersG Chételat, M Fouquet
Revue Neurologique|May 1, 2004
[Brain substrates of episodic memory disorders in Alzheimer's disease]B Desgranges, G Chételat, F Eustache
Revue Neurologique|October 10, 2006
[Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy]G Chételat, B Desgranges, F Eustache
Revue Neurologique|October 10, 2006
[Alzheimer's disease and human memory]F Eustache, B Giffard, G Rauchs, et al.
Revue Neurologique|May 1, 2004
[At the boundary between normal aging and Alzheimer disease]G Chételat, B Desgranges, V de la Sayette, et al.
Revue Neurologique|March 16, 2010
[The default mode network: cognitive role and pathological disturbances]K Mevel, B Grassiot, G Chételat, et al.
La Revue De Medecine Interne|March 4, 2020
[White matter hyperintensities in ageing: Pathophysiology, associated cognitive disorders and prevention]A Garnier-Crussard, V Desestret, F Cotton, et al.
Neurology|April 13, 2012
Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholismA-L Pitel, G Chételat, A P Le Berre, et al.
Neurology|April 23, 2003
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?G Chételat, B Desgranges, V de la Sayette, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revue Neurologique|May 3, 2022
How to use neuroimaging biomarkers in the diagnosis framework of neurodegenerative diseases?G Chételat
Revue Neurologique|September 11, 2013
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriersG Chételat, M Fouquet
Revue Neurologique|May 1, 2004
[Brain substrates of episodic memory disorders in Alzheimer's disease]B Desgranges, G Chételat, F Eustache
Revue Neurologique|October 10, 2006
[Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy]G Chételat, B Desgranges, F Eustache
Revue Neurologique|October 10, 2006
[Alzheimer's disease and human memory]F Eustache, B Giffard, G Rauchs, et al.
Revue Neurologique|May 1, 2004
[At the boundary between normal aging and Alzheimer disease]G Chételat, B Desgranges, V de la Sayette, et al.
Revue Neurologique|March 16, 2010
[The default mode network: cognitive role and pathological disturbances]K Mevel, B Grassiot, G Chételat, et al.
La Revue De Medecine Interne|March 4, 2020
[White matter hyperintensities in ageing: Pathophysiology, associated cognitive disorders and prevention]A Garnier-Crussard, V Desestret, F Cotton, et al.
Neurology|April 13, 2012
Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholismA-L Pitel, G Chételat, A P Le Berre, et al.
Neurology|April 23, 2003
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?G Chételat, B Desgranges, V de la Sayette, et al.
Pageof 2